Electrotransport transdermal system

Claim 2

An electrotransport system for placement on a body surface and delivering an agent through said surface, the system comprising: a non-conductive backing member; a source of electrical power comprising first and second current conducting members, said current conducting members being positioned adjacent to said backing member; a first electrode pad comprising a first reservoir containing an electrolyte and a second reservoir containing the agent, said electrolyte-containing reservoir, positioned adjacent to said first current conducting member and said agent-containing reservoir adapted to be positioned in current conducting relationship to said body surface; a selectively permeable membrane separating the first and second reservoirs from one another, the membrane comprising a microporous polymer which is impermeable to the agent and to chemical species having a molecular weight greater than a predetermined molecular weight and permeable to chemical species having a molecular weight less than the predetermined molecular weight; a second electrode pad positioned adjacent to said second current conducting member and adapted to be positioned in current conducting relationship to said body surface; an insulating means electrically insulating said first and said second electrode pads from each other; and a means for maintaining said system in current conducting and agent transmitting relationship to said body surface.

Claim 3

A self contained electrotransport transdermal system for placement on a body surface and delivering an agent through said surface, the system comprising: a non-conductive backing member; a source of electrical power comprising first and second current conducting members, said current conducting members being positioned adjacent to said backing member, said first current conducting member being composed at least in part of an oxidizable metal; a first electrode pad comprising a first reservoir containing an electrolyte and a second reservoir containing the agent, said electrolyte-containing reservoir positioned adjacent to said first current conducting member and said agent-containing reservoir adapted to be positioned in current conducting relationship to said body surface; a selectively permeable membrane separating the first and second reservoirs from one another, the membrane comprising a hydrogel material which is loaded with a chelating agent, the loaded hydrogel material being capable of trapping metal ions produced by the oxidation of the metal in the first current conducting member; a second electrode pad positioned adjacent to said second current conducting member and adapted to be positioned in current conducting relationship to said body surface; an insulating means electrically insulating said first and said second electrode pads from each other; and a means for maintaining said system in current conducting and agent transmitting relationship to said body surface.

Claim 4

A self contained electrotransport transdermal system for placement on a body surface and delivering an agent through said surface, the system comprising: a non-conductive backing member; a source of electrical power comprising first and second current conducting members, said current conducting members being positioned adjacent to said backing member, said first current conducting member being composed at least in part of an oxidizable metal; a first electrode pad comprising a first reservoir containing an electrolyte and a second reservoir containing the agent, said electrolyte-containing reservoir positioned adjacent to said first current conducting member and said agent-containing reservoir adapted to be positioned in current conducting relationship to said body surface; a selectively permeable membrane separating the first and second reservoirs from one another, the membrane comprising a hydrogel material which is loaded with a chelating agent, the loaded hydrogel material being capable of trapping metal ions produced by the oxidation of the metal in the first current conducting member; a second electrode pad positioned adjacent to said second current conducting member and adapted to be positioned in current conducting relationship to said body surface; an insulating means electrically insulating said first and said second electrode pads from each other; and a means for maintaining said system in current conducting and agent transmitting relationship to said body surface.

Claim 5

The system of claim 1 or 2, wherein said second electrode pad contains an agent to be delivered.

Claim 6

The system of claim 1 or 2, wherein said means for maintaining said system in current conducting and agent transmitting relationship to said body surface is a peripheral adhesive.

Claim 7

The system of claim 1 or 2, wherein said means for maintaining said system in current conducting and agent transmitting relationship to said body surface is an adhesive overlay.

Claim 8

The system of claim 1 or 2, wherein said means for maintaining said system in current conducting and agent transmitting relationship to said body surface is an in-line ion conducting adhesive positioned between said electrode pads and said body surface.

Claim 9

The system of claim 1 or 2, wherein said means for maintaining said system in current conducting and agent transmitting relationship to said body surface comprises utilizing a self-adhering matrix composition for said agent-containing reservoir of said first electrode pad, and said second electrode pad.

Claim 10

The system of claim 1 or 2, wherein said first electrode pad, said insulating means and said second electrode pad are aligned in parallel.

Claim 11

The system of claim 1 or 2, wherein said first electrode pad, said insulating means and said second electrode pad are peripherally aligned.

Claim 12

The system of claim 1 or 2, wherein said agent is a macromolecule.

Claim 13

The system of claim 1 or 2, wherein said agent is selected from the group consisting of peptides and polypeptides.

Claim 14

The system of claim 1 or 2, wherein said agent is selected from the group consisting of metoclopramide, baclofen, betamethasone, beclomethasone, doxazosin, droperidol, fentanyl, sufentanil, leuprolide, lidocaine, methotrexate, micanazole, prazosin, piroxicam, verapamil, tetracaine, diltiazam, indomethacin, hydrocortisone, terbutaline and encainide.

Claim 15

The system of claim 1 or 2, wherein said source of electrical power includes a battery.

Claim 16

The system of claim 1 or 2, wherein said source of electrical power includes a galvanic couple formed by the first and second current conducting members contacting one another, said first and second current conducting members being formed of different metals.

Claim 17

The system of claim 1 or 2, wherein said source of electrical power produces a constant current.

Claim 18

The system of claim 1 or 2, wherein said source of electrical power is controlled by a patient.

Claim 19

The system of claim 1 or 2, which further comprises a microprocessor for controlling current produced by the source of electrical power as a function of time.

Claim 20

The system of claim 1 or 2, having a feedback system including a sensor for monitoring a biosignal and means for controlling current produced by the electrical power source in response thereto.

Claim 21

The system of claim 2, wherein the hydrogel material is partially cross-linked.

Claim 22

The system of claim 2, wherein the hydrogel material is selected from the group consisting of polyvinyl alcohol, polyacrylamide, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxymethyl cellulose, polyacrylic acid, polyvinyl pyrrolidone, hydroxyethyl methacrylate, albumin, gelatin and cellulose.

Claim 23

The system of claim 2, wherein the chelating agent comprises EDTA.